Can I Take Calcium with Prometrium?

What Prometrium Is and Why It Matters in HRT

Prometrium is the brand name for oral micronized progesterone, a bioidentical progestogen manufactured by AbbVie and FDA-approved since 1998. Its primary role in menopause management is to protect the endometrium from unopposed estrogen stimulation in women who retain a uterus. The capsule contains progesterone dissolved in peanut oil, and the micronization process (particle size reduced to below 10 microns) dramatically improves oral bioavailability compared to non-micronized formulations.

How the Body Absorbs Micronized Progesterone

Oral micronized progesterone undergoes extensive first-pass hepatic metabolism. Peak serum concentrations (Cmax) arrive roughly 2 to 3 hours post-dose, and the elimination half-life ranges from 16 to 18 hours in most patients [1]. Because food increases bioavailability by as much as threefold, Prometrium prescribing information explicitly instructs patients to take it with food, and the bedtime-with-snack schedule is widely used clinically to minimize next-morning sedation from the neurosteroid metabolites (notably allopregnanolone) that accumulate after oral dosing [2].

Why Bioidentical Progesterone Is Preferred Over Synthetic Progestins

The KEEPS trial (Kronos Early Estrogen Prevention Study, N=727) and the ESHRE/ESGE guidelines both favor oral micronized progesterone over medroxyprogesterone acetate (MPA) in part because of a more favorable lipid profile and reduced platelet aggregation. The WHI trial (N=16,608), which used conjugated equine estrogen plus MPA, documented a relative risk of breast cancer of 1.26 in the combined-therapy arm; subsequent observational data from the E3N cohort (N=98,997) found no statistically significant increase in breast cancer risk with estrogen plus micronized progesterone [3]. That distinction matters when counseling women about long-term HRT safety and is relevant to how we think about co-supplementation decisions.

Does Calcium Interact with Prometrium? The Direct Answer

No clinically significant interaction between calcium and micronized progesterone has been established in peer-reviewed pharmacokinetic or pharmacodynamic studies. The FDA-approved prescribing information for Prometrium does not list calcium salts in its drug-interaction section [2]. The Natural Medicines Database (accessed January 2025) classifies the combination as having insufficient evidence of interaction, not a contraindication.

Why People Worry About the Combination

The concern stems from calcium's well-documented ability to bind or chelate other compounds in the gastrointestinal tract, reducing their absorption. This mechanism is clinically significant for:

• Levothyroxine: a 4-hour separation is recommended because calcium carbonate reduces T4 absorption by roughly 20 to 30% [4]
• Bisphosphonates (alendronate, risedronate): calcium must be separated by at least 30 minutes to avoid chelation-driven bioavailability loss
• Certain fluoroquinolone and tetracycline antibiotics

Prometrium does not share these binding vulnerabilities. Progesterone is a lipophilic steroid dissolved in oil. Its absorption pathway (passive diffusion through enterocytes, lymphatic transport, then systemic circulation) is not dependent on the ion-transporter mechanisms that calcium-mineral chelation disrupts.

The Cardiovascular Picture

A separate, indirect concern is cardiovascular risk. The Women's Health Initiative Calcium/Vitamin D trial (WHI-CaD, N=36,282) reported a possible increase in myocardial infarction risk with calcium supplementation in some subgroups, though results were disputed and a subsequent meta-analysis in the BMJ (Bolland et al., 2011) calculated a hazard ratio of 1.27 for MI with calcium alone [5]. Women on combined HRT who also supplement calcium should have this risk discussed with their clinician. The risk does not represent a Prometrium-specific interaction; it is a calcium supplement issue that runs alongside any medication regimen.

Timing Your Doses: A Practical Schedule

Separating doses by two hours protects against any theoretical GI competition and imposes no meaningful burden on most patients. The schedule below applies to women taking a standard menopausal HRT regimen.

Sample Daily Timing Protocol

| Time | Action | |------|--------| | 7:00 AM | Oral estrogen (estradiol 0.5 to 2 mg or estradiol patch changed twice weekly) | | 8:00 AM | Levothyroxine (if prescribed) on empty stomach | | 10:00 AM | Calcium citrate 500 mg + vitamin D3 1,000 IU | | With dinner | Second calcium citrate dose 500 mg (if total daily target is 1,000 to 1,200 mg) | | Bedtime with snack | Prometrium 100 mg or 200 mg |

This schedule provides a natural two-hour minimum gap between any calcium dose and Prometrium. The bedtime timing of Prometrium also leverages the sedative metabolite profile, improving adherence and sleep quality in many perimenopausal and postmenopausal women.

Calcium Form Matters

Calcium citrate is absorbed independently of gastric acid and food, making it more flexible than calcium carbonate for women on proton pump inhibitors or with achlorhydria. Calcium carbonate requires an acidic environment and is best taken with a meal. Neither form is contraindicated with Prometrium, but calcium citrate's timing flexibility makes dose-separation easier to execute consistently.

The National Osteoporosis Foundation and the USPSTF both note that dietary calcium (dairy, fortified foods, leafy greens) should be prioritized before reaching for supplements, and that total calcium intake above 1,200 mg/day in postmenopausal women offers diminishing bone benefit while potentially increasing kidney stone risk [6].

What the Guidelines Say About HRT and Bone Protection

Postmenopausal women prescribed HRT are often the same women at risk for osteoporosis, and calcium plus vitamin D is a foundational co-intervention in most bone-protection protocols.

NAMS Position Statement

The North American Menopause Society (NAMS) 2022 Hormone Therapy Position Statement states: "Hormone therapy is the most effective treatment for vasomotor symptoms and is effective for prevention of osteoporosis-related fractures, provided it is initiated at an appropriate time and at sufficient doses" [7]. The same document notes that co-administration of adequate calcium and vitamin D is expected practice in women on HRT, with no special precautions regarding progestogen type.

Endocrine Society Clinical Practice Guideline

The Endocrine Society's 2015 Clinical Practice Guideline on menopause recommends 1,000 mg of calcium daily for women aged 50 years and younger and 1,200 mg for women older than 50, ideally from dietary sources [8]. Vitamin D sufficiency (25-OH vitamin D above 30 ng/mL) is recommended in parallel with any hormone therapy regimen.

The HealthRX clinical team uses a three-step co-supplementation check before finalizing any Prometrium regimen alongside supplements:

Step 1. Identify all mineral-chelation-sensitive drugs in the patient's stack (levothyroxine, bisphosphonates, fluoroquinolones, iron). These require strict dose-separation from calcium and should be scheduled before calcium timing is determined.

Step 2. Anchor Prometrium at bedtime. Because Prometrium's bioavailability is enhanced by food and because its neurosteroid metabolites promote sleep, the bedtime-with-snack slot nearly always places it at least 4 hours after any calcium dose.

Step 3. Confirm vitamin D adequacy. Calcium supplementation is far less effective without adequate vitamin D. A baseline 25-OH vitamin D level at HRT initiation, with a target of 40 to 60 ng/mL, is standard HealthRX practice before determining the appropriate calcium supplement dose.

Who Needs Extra Caution

Most women taking Prometrium alongside calcium will have no problems. Certain subgroups warrant more individualized attention.

Women Also Taking Levothyroxine

Hypothyroidism and menopause commonly overlap in women between 45 and 60 years of age. If levothyroxine is already part of the regimen, calcium must be separated from the thyroid medication by at least 4 hours (FDA prescribing information for levothyroxine), and Prometrium should still be placed at bedtime. A practical schedule is levothyroxine on waking, calcium mid-morning, and Prometrium at bedtime.

Women Also Taking Bisphosphonates

Oral alendronate (Fosamax 70 mg weekly) or risedronate must be taken on an empty stomach with plain water and followed by 30 minutes of upright posture before any food, drink, or supplements. Women taking both a bisphosphonate and Prometrium plus calcium should dose the bisphosphonate on waking, take Prometrium at bedtime, and place calcium with meals or at least 30 minutes after the bisphosphonate has been absorbed.

Women With Hypercalcemia or a History of Kidney Stones

Serum calcium above 10.5 mg/dL (the upper limit of normal in most laboratory reference ranges) is a reason to investigate primary hyperparathyroidism before supplementing calcium. Prometrium itself does not raise serum calcium. If hypercalcemia is confirmed, calcium supplementation should be paused regardless of the Prometrium schedule.

Women With Liver Disease

Because Prometrium undergoes extensive hepatic first-pass metabolism, moderate-to-severe liver disease can raise progesterone metabolite levels unpredictably. Calcium metabolism is not directly affected by hepatic disease unless cholestasis impairs fat-soluble vitamin D absorption. Women with active liver disease should have hepatic function assessed before starting Prometrium at any dose [2].

Monitoring Recommendations on Combined HRT Plus Calcium

Ongoing surveillance keeps the regimen safe. The following schedule represents a reasonable minimum.

At Baseline (Before Starting or Within 60 Days of Starting)

• Serum calcium and phosphorus
• 25-OH vitamin D
• Complete metabolic panel (including hepatic enzymes)
• Fasting lipid panel
• Mammogram (per age-appropriate USPSTF screening guidelines)
• Endometrial assessment if indicated by bleeding history

At 3 Months

• Symptom review (vasomotor, sleep, mood)
• Blood pressure (some women show mild BP changes on combined HRT)
• Any new supplement additions reviewed for interactions

Annually

• Fasting lipid panel (estrogen raises HDL; progestogen effects vary by type)
• Serum calcium if supplementing above 1,000 mg/day
• 25-OH vitamin D
• Bone density (DXA scan every 1 to 2 years in women with osteopenia or osteoporosis)

A 2023 review in Menopause (the journal of NAMS) covering 47 studies concluded that women using oral micronized progesterone had significantly lower rates of venous thromboembolism than those using synthetic progestins, with an odds ratio of approximately 0.7 [9]. That finding does not change the calcium co-supplementation guidance, but it reinforces why choosing Prometrium over MPA matters in a broad risk-benefit calculation.

Vitamin D: The Missing Piece Most Patients Overlook

Calcium and Prometrium are often discussed in isolation from vitamin D, but the three are functionally linked in postmenopausal bone health.

Why Vitamin D Status Changes the Calcium Math

Vitamin D3 (cholecalciferol) is converted in the liver to 25-OH vitamin D and then in the kidney to 1,25-dihydroxyvitamin D (calcitriol), which upregulates intestinal calcium transport proteins. Without sufficient calcitriol, calcium absorption from the gut falls to roughly 15% of ingested dose, compared to 30 to 40% in vitamin D-replete individuals [10]. Supplementing 1,200 mg of calcium daily in a vitamin D-deficient woman produces far less bone benefit than 800 mg in a woman with a 25-OH level above 40 ng/mL.

Recommended Vitamin D Doses on HRT

The Endocrine Society recommends 600 to 800 IU of vitamin D3 daily as a dietary reference intake for adults, but notes that many patients require 1,500 to 2,000 IU daily to maintain serum levels above 30 ng/mL [11]. Postmenopausal women with baseline deficiency (25-OH below 20 ng/mL) may need 4,000 IU daily for 8 to 12 weeks before dropping to a maintenance dose. Vitamin D3 has no known interaction with Prometrium.

Frequently Asked Questions